Literature DB >> 2693610

Mutants of the hepatitis B virus surface antigen that define some antigenically essential residues in the immunodominant a region.

P G Ashton-Rickardt1, K Murray.   

Abstract

The nature of the immunodominant a region of hepatitis B virus surface antigen (HBsAg) has been examined by mutation of specific amino acid residues. Proline 142 was required for the exhibition of full antigenicity. Replacement of cysteines 124 and 147 by serines drastically reduced or eliminated reactivity with antibodies to HBsAg, which implicates these two residues in stabilising the conformation of the antigen. The a region of HBsAg has also been shown to influence both the immunoreactivity of the adjacent subtype antigenic region, despite being immunologically distinct from it, and the ability of the antigen to interact with a subtype-specific monoclonal antibody. These results emphasise the importance of the polypeptide region between cysteine residues 124 and 147 in determining a antigenicity, as well as manifestation of the subtype of HBsAg, and reinforce the view that these are conformational epitopes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693610     DOI: 10.1002/jmv.1890290310

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

Authors:  J A Waters; M Kennedy; P Voet; P Hauser; J Petre; W Carman; H C Thomas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens.

Authors:  Azam Roohi; Yaghoub Yazdani; Jalal Khoshnoodi; Seyed Mohammad Jazayeri; William F Carman; Mahmood Chamankhah; Manley Rashedan; Fazel Shokri
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

Authors:  M Triyatni; A R Jilbert; M Qiao; D S Miller; C J Burrell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.

Authors:  G Borisova; B Arya; A Dislers; O Borschukova; V Tsibinogin; D Skrastina; M A Eldarov; P Pumpens; K G Skryabin; E Grens
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier.

Authors:  Wenbin Tong; Li Sun; Jilan He; Shusen He; Fei Du
Journal:  Virol J       Date:  2010-05-22       Impact factor: 4.099

6.  Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein.

Authors:  C M Mangold; R E Streeck
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Hepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient.

Authors:  Alexandra Alexopoulou; Gerasimos Baltayiannis; Saffie Jammeh; Jenny Waters; Spyros P Dourakis; Peter Karayiannis
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide.

Authors:  M W Pride; H Shi; J M Anchin; D S Linthicum; P T LoVerde; A Thakur; Y Thanavala
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 9.  Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences.

Authors:  Xinyi Jiang; Le Chang; Ying Yan; Lunan Wang
Journal:  Int J Biol Sci       Date:  2021-03-11       Impact factor: 6.580

10.  Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China.

Authors:  Xing-Bin Hu; Qiao-Hong Yue; Xian-Qing Zhang; Xue-Qing Xu; Yin Wen; Yao-Zhen Chen; Xiao-Dong Cheng; Liu Yang; Shi-Jie Mu
Journal:  Virol J       Date:  2009-11-17       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.